XML 21 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisition of Sangamo Therapeutics France S.A.S. - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Nov. 23, 2018
Oct. 01, 2018
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Jul. 20, 2018
Business Acquisition [Line Items]                
Purchase of additional Sangamo France shares         $ 262,000 $ 0    
Goodwill impairments         $ 0   $ 0  
TxCell S.A.                
Business Acquisition [Line Items]                
Number of ordinary shares acquired (in shares)   13,519,036 111,000 11,528,635        
Purchase of additional Sangamo France shares     $ 300,000          
Purchase price per share (usd per share)   $ 2.99            
TxCell S.A. | Share Purchase Agreement and Tender Offer Agreement                
Business Acquisition [Line Items]                
Percentage of equity interests agreed to acquire               100.00%
Number of ordinary shares acquired (in shares) 11,528,635   111,000 25,047,671        
Number of free shares held by the holders (in shares)   477,000 477,000   477,000      
Purchase of additional Sangamo France shares     $ 300,000          
Estimated fair value liability of free shares   $ 200,000            
Estimated fair value asset of free shares     $ 200,000   $ 200,000      
TxCell S.A. | Share Purchase Agreement and Tender Offer Agreement | Option Pricing Method                
Business Acquisition [Line Items]                
Estimated fair value liability of free shares   $ 200,000   $ 200,000     $ 200,000  
TxCell S.A. | Share Purchase Agreement and Tender Offer Agreement | Former Executive of TxCell                
Business Acquisition [Line Items]                
Number of ordinary shares acquired (in shares)     52,700          
TxCell S.A. | SPA                
Business Acquisition [Line Items]                
Number of ordinary shares acquired (in shares)   13,519,036            
TxCell S.A.                
Business Acquisition [Line Items]                
Noncontrolling interest ownership percentage     98.70% 98.20% 98.70%   98.20%  
TxCell S.A. | Share Purchase Agreement and Tender Offer Agreement                
Business Acquisition [Line Items]                
Noncontrolling interest ownership percentage     98.70% 98.20% 98.70%   98.20%